Pediatrik Nefroloji, Nefrogenetik Laboratuvarı

Hakkında

Herediter böbrek hastalıklarının genetiğine adanmış rutin diagnostik ve araştırma temelli çalışmaların yürütüldüğü Türkiye’nin ilk Nefrogenetik laboratuvarıdır.

Araştırma Olanakları

•    Konvansiyonel Termal Cycler (3 adet)
•    Real-Time PCR (1 adet)
•    Sekans cihazı (Applied 3130)
•    İkinci nesil dizileme cihazı (S5 ve Ion Chef sistem)
•    Normal ve soğutmalı santrifüj (2 adet)
•    DNA konsantratörü, derin dondurucu (-80 ve -20)
•    Sıvı nitrojen tankı (-180)
•    Class II biyolojik güvenlik kabini
•    İnverted mikroskop
•    Buzdolapları (2 adet)
•    Jel elektroforez sistemleri (konvansiyonel ve otomatik)
•    DNA/RNA izolasyon robotu

Araştırmacılar

•    Prof. Dr. Fatih Özaltın
•    Biyolog Dr. Emine Atayar
•    Biyolog Doruk Taylan
•    Teknisyen Serpil Solmaz
•    Teknisyen Mustafa Baran

Devam Eden Projeler

  • Adolesan başlangıçlı atipik hemolitik üremik sendrom hastalarında kompleman düzenleyici genlerdeki mutasyonların saptanması ve hastaların klinik özelliklerinin incelenmesi (H.Ü. Kapsamlı Araştırma Projesi-TSA-2019-18022)
  • Kalıtsal Nadir Böbrek Hastalıklarında Yeni Genlerin Araştırılması (Cerrahpaşa Tıp Fakültesi ÖNAP Projesi-TOA-2021-35349)
     

Tamamlanan Projeler

  •  Çocukluk Çağı Otozomal Dominant ve Otozomal Resesif Polikistik Böbrek Hastalıklarının Genetik ve Klinik Özelliklerinin Araştırılması (H.Ü. Tıpta Uzmanlık Tez Projesi- TTU-2019-17817)
  • EURenOmics (European Consortium for High-Throughput Research in Rare Kidney Diseases) (AB 7.Çerçeve projesi (Proje No: 305608)
  •  Atipik Hemolitik Üremik Sendromlu Hastalarda Kompleman Düzenleyici Genlerdeki Mutasyonların Saptanması (HÜ Araştırma Projesi-010 A 101 009-104)
  • Çocuk çağı böbrek hastalıklarında yeni genlerin tanımlanması (İstanbul Üniversitesi Cerrahpaşa BAP Projesi, Proje No: 55436)
  • CoQ10 Nefropatisinde Koenzim Q10 İçerikli Nanoterapötiklerin Tedavi Etkiliğinin Araştırılması ve İn Vitro Modelde Mitokondriyal Fonksiyonlarının Karşılaştırılması (HÜ Kapsamlı Araştırma Projesi-TSA-2018-16993)
  • Nadir Bir Hastalık Olan Sistinozis Tanısında ve İzleminde Kullanılabilecek Yeni Biyobelirteçlerin Araştırılması: Klinik ve İn Vitro Temelli Multiomik (Genomik, Proteomik, Metabolomik ve Fluksomik) Çalışmalar (TÜBİTAK 1001 projesi-118S578)

Yayınlar

  1. Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schreuder MF, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Liu C, Sun S, Deng F, Wang X, Clavé S, Stańczyk M, Bałasz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G; PodoNet Consortium; MitoNet Consortium; CCGKDD Consortium, Schaefer F. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency. Kidney Int. 2022 May 25:S0085-2538(22)00379-9. doi: 10.1016/j.kint.2022.04.029
  2. Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Ziętkiewicz S, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schijvens AM, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Deng F, Rousset-Rouviere C, Stańczyk M, Bałasz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G; PodoNet Consortium; mitoNET Consortium; CCGKDD Consortium, Schaefer F. Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy. Kidney Int. 2022 Apr 26:S0085-2538(22)00338-6. doi: 10.1016/j.kint.2022.02.040
  3. Sena Ozbay H, Yabanoglu-Ciftci S, Baysal I, Gultekinoglu M, Can Eylem C, Ulubayram K, Nemutlu E, Topaloglu R, Ozaltin F. Mitochondria-Targeted CoQ 10 Loaded PLGA-b-PEG-TPP Nanoparticles: Their Effects on Mitochondrial Functions of COQ8B -/- HK-2 cells. Eur J Pharm Biopharm. 2022 Feb 26:S0939-6411(22)00039-X. doi: 10.1016/j.ejpb.2022.02.018
  4. Baskin E, Fidan K, Gulhan B, Gulleroglu K, Canpolat N, Yilmaz A, Parmakiz G, Özçakar ZB, Ozaltin F, Soylemezoglu O. Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study. J Nephrol 2022 Jan 21. doi: 10.1007/s40620-021-01212-w
  5. Yılmaz EK, Saygili S, Gulhan B, Canpolat N, Bayazıt AK, Kilic BD, Akıncı N, Benzer M, Goknar N, Tufan AK, Kalyoncu M, Nalcacioglu H, Tekcan D, Yıldız G, Agbas A, Nayır A, Topaloglu R, Caliskan S, Ozaltin F. A broad clinical spectrum of PLCε1-related kidney disease and intrafamilial variability. Pediatr Nephrol. 2022; 16. doi: 10.1007/s00467-021-05371-7
  6. Airik M, McCourt B, Ozturk TT, Huynh AB, Zhang X, Tometich JT, Topaloglu R, Ozen H, Orhan D, Nejak-Bowen K, Monga SP, Hand TW, Ozaltin F, Airik R. Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion  FASEB J. 2022 Feb;36(2):e22157
  7. Özlü SG, Gülhan B, Aydoğ Ö, Atayar E, Delibaş A, Parmaksız G, Özdoğan EB, Çomak E, Taşdemir M, Acar B, Özçakar ZB, Topaloğlu R, Söylemezoğlu O, Özaltın F. Could plasma based therapies still be considered in selected cases with atypical hemolytic uremic syndrome? Turk J Pediatr. 2021;63: 986-993
  8. Canpolat N, Liu D, Atayar E, Saygili S, Kara NS, Westfall TA, Ding Q, Brown BJ, Braun TA, Slusarski D, Karli Oguz K, Ozluk Y, Tuysuz B, Tastemel Ozturk T, Sever L, Sezerman OU, Topaloglu R, Caliskan S, Attanasio M, Ozaltin F. A splice site mutation in the TSEN2 causes a new syndrome with craniofacial and central nervous system malformations, and atypical hemolytic uremic syndrome. Clin Genet. 2022; 101: 346-358
  9. Emma F, Hoff WV, Hohenfellner K, Topaloglu R, Greco M, Ariceta G, Bettini C, Bockenhauer D, Veys K, Pape L, Hulton S, Collin S, Ozaltin F, Servais A, Deschênes G, Novo R, Bertholet-Thomas A, Oh J, Cornelissen E, Janssen M, Haffner D, Ravà L, Antignac C, Devuyst O, Niaudet P, Levtchenko E. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis. Kidney Int. 2021; 100: 1112-1123
  10. Boyer O, Schaefer F, Haffner D, Bockenhauer D, Hölttä T, Bérody S, Webb H, Heselden M, Lipska-Zie Tkiewicz BS, Ozaltin F, Levtchenko E, Vivarelli M. Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group. Nat Rev Nephrol. 2021 Apr;17(4):277-289. doi: 10.1038/s41581-020-00384-1.
  11. Demir S, Gülhan B, Özen S, Çeleğen K, Batu ED, Taş N, Orhan D, Bilginer Y, Düzova A, Ozaltin F, Topaloğlu R. Long term renal survival of pediatric patients with lupus nephritis.Nephrol Dial Transplant. 2021 Apr 7:gfab152. doi: 10.1093/ndt/gfab152.
  12. Demirgan EB, Saygili S, Canpolat N, Sever L, Kilicaslan I, Taylan D, Caliskan S, Ozaltin F. AGTR1-related renal tubular dysgeneses may not be fatal. Kidney Int Rep. 2020 Dec 13;6(3):846-852. doi: 10.1016/j.ekir.2020.11.033.
  13. Özçakar ZB, Ozaltin F, Gülhan B et al. Transplantation in pediatric aHUS within the era of eculizumab therapy. Pediatr Transplant. 2021 May;25(3):e13914. doi: 10.1111/petr.13914.
  14. Topaloglu R, Keser AG, Gülhan B, Ozaltin F, Demir H, Çiftci T, Demir N, Temucin ÇM, Yuce A, Akhan O. Cystinosis beyond kidneys: gastrointestinal system and muscle involvement. BMC Gastroenterol. 2020 Jul 29;20(1):242. doi: 10.1186/s12876-020-01385-x
  15. Saygili S, Atayar E, Canpolat N, Elicevik M, Kurugoglu S, Sever L, Caliskan S, Ozaltin F. A homozygous HOXA11 variation as a potential novel cause of autosomal recessive congenital anomalies of the kidney and urinary tract. Clin Genet. 2020 Oct;98(4):390-395. doi: 10.1111/cge.13813.
  16. Ozdemir G, Gulhan B, Atayar E, Saygılı S, Soylemezoglu O, Ozcakar ZB, Eroglu FK, Candan C, Demir BK, Soylu A, Yüksel S, Alpay H, Agbas A, Duzova A, Hayran M, Ozaltin F, Topaloglu R. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome. Pediatr Nephrol. 2020 Oct;35(10):1941-1952. doi: 10.1007/s00467-020-04574-8.
  17. Atmaca M, Gülhan B, Atayar E, Bayazıt AK, Candan C, Arıcı M, Topaloğlu R, Özaltın F. Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementation. Turk J Pediatr. 2019;61(5):657-663. doi: 10.24953/turkjped.2019.05.003
  18. Güngör T, Eroğlu FK, Kargın Çakıcı E, Yazılıtaş F, Can G, Çelikkaya E, Karakaya D, Kurt Şükür ED, Özaltın F, Yağız B, Bülbül M. Gastric duplication cyst in an infant with Finnish-type congenital nephrotic syndrome: concurrence or coincidence? Acta Clin Belg. 2019 Oct 5:1-3. doi: 10.1080/17843286.2019.1675333
  19. Eroglu FK, Ozaltin F, Gönç N, Nalçacıoğlu H, Özçakar ZB, Yalnızoğlu D, Güçer Ş, Orhan D, Eminoğlu FT, Göçmen R, Alikaşifoğlu A, Topaloğlu R, Düzova A. Response to Early Coenzyme Q10 Supplementation Is not Sustained in CoQ10 Deficiency Caused by CoQ2 Mutation. Pediatr Neurol. 2018 Nov;88:71-74. doi: 10.1016/j.pediatrneurol.2018.07.008
  20. Akyol A, Güner G, Özşeker HS, Işık A, Atcı Ö, Uzun S, Atayar E, Ozaltin F, Gedikoğlu G, Sökmensüer C, Fearon ER. An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues. Lab Invest. 2019 Jan;99(1):128-137. doi: 10.1038/s41374-018-0121-9.
  21. Sürmeli-Döven S, Delibaş A, Gürses İ, Kayacan UR, Coşkun-Yılmaz B, Esen K, Korkmaz E, Özaltın F. Hemolytic uremic syndrome and IgA nephropathy in a child: Coincidence or not? Turk J Pediatr. 2018;60(1):81-85. doi: 10.24953/turkjped.2018.01.012
  22. Saygili S, Canpolat N, Sever L, Caliskan S, Atayar E, Ozaltin F. Persistent hypoglycemic attacks during hemodialysis sessions in an infant with congenital nephrotic syndrome: Answers. Pediatr Nephrol. 2019 Jan;34(1):77-79. doi: 10.1007/s00467-018-3982-7.
  23. Saygili S, Canpolat N, Sever L, Caliskan S, Atayar E, Ozaltin F. Persistent hypoglycemic attacks during hemodialysis sessions in an infant with congenital nephrotic syndrome: Questions. Pediatr Nephrol. 2019 Jan;34(1):75-76. doi: 10.1007/s00467-018-3980-9.
  24. Fidan K, Göknar N, Gülhan B, Melek E, Yıldırım ZY, Baskın E, Hayran M, Gülleroglu K, Özçakar ZB, Ozaltin F, Soylemezoglu O. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2018 Aug;33(8):1395-1403. doi: 10.1007/s00467-018-3933-3
  25. Çakar N, Ozcakar ZB, Ozaltin F, Koyun M, Celikel Acar B, Bahat E, Gulhan B, Korkmaz E, Yurt A, Yılmaz S, Soylemezoglu O, Yalcinkaya F. Atypical Hemolytic Uremic Syndrome in Children Aged <2 Years. Nephron. 2018;139(3):211-218. doi: 10.1159/000487609. Epub 2018 Mar 13.
  26. Warejko JK, Tan W, Daga A, Schapiro D, ……., Ozaltin F, ……Lifton RP, Braun DA, Hildebrandt F. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2018 Jan 6;13(1):53-62. doi: 10.2215/CJN.04120417
  27. Braun DA, Rao J, Mollet G, Schapiro D, ……. Ozaltin F, ………., Zenker M, Antignac C, Hildebrandt F. Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly. Nat Genet. 2017 Oct;49(10):1529-1538. doi: 10.1038/ng.3933
  28. Lipska-Ziętkiewicz BS, Gellermann J, Boyer O, Gribouval O, Ziętkiewicz S, Kari JA, Shalaby MA, Ozaltin F, Dusek J, Melk A, Bayazit AK, Massella L, Hyla-Klekot L, Habbig S, Godron A, Szczepańska M, Bieniaś B, Drożdż D, Odeh R, Jarmużek W, Zachwieja K, Trautmann A, Antignac C, Schaefer F; PodoNet Consortium. Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia. PLoS One. 2017 Aug 10;12(8):e0180926. doi: 10.1371/journal.pone.0180926
  29. Topaloglu R, Gulhan B, İnözü M, Canpolat N, Yilmaz A, Noyan A, Dursun İ, Gökçe İ, Gürgöze MK, Akinci N, Baskin E, Serdaroğlu E, Demircioğlu Kiliç B, Yüksel S, Övünç Hacihamdioğlu D, Korkmaz E, Hayran M, Ozaltin F; contributors of The Turkish Cystinosis Study Group. The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis. Clin J Am Soc Nephrol. 2017 Aug 9;12(10):1634-41. doi: 10.2215/CJN.00180117
  30. Trautmann A, Schnaidt S, Lipska-Ziętkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F; PodoNet Consortium. Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. J Am Soc Nephrol. 2017 Oct;28(10):3055-3065. doi: 10.1681/ASN.2016101121
  31. Kayki G, Bozkaya D, Ozaltin F, Orhan D, Kaymaz F, Korkmaz E, Yigit S. Epidermolysis Bullosa with Pyloric Atresia and Aplasia Cutis in a Newborn Due to Homozygous Mutation in ITGB4. Fetal Pediatr Pathol. 2017 Aug;36(4):332-339. doi: 10.1080/15513815.2017.1324545
  32. Atmaca M, Gulhan B, Korkmaz E, Inozu M, Soylemezoglu O, Candan C, Bayazıt AK, Elmacı AM, Parmaksiz G, Duzova A, Besbas N, Topaloglu R, Ozaltin F. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment. Pediatr Nephrol. 2017 Aug;32(8):1369-1375. doi: 10.1007/s00467-017-3634-3
  33. Besbas N, Gulhan B, Soylemezoglu O, Ozcakar ZB, Korkmaz E, Hayran M, Ozaltin F. Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients. BMC Nephrol. 2017 Jan 5;18(1):6. doi: 10.1186/s12882-016-0420-6.
  34. Hölttä T, Bonthuis M, Van Stralen KJ, Bjerre A, Topaloglu R, Ozaltin F, Holmberg C, Harambat J, Jager KJ, Schaefer F, Groothoff JW. Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry. Pediatr Nephrol. 2016 Dec;31(12):2317-2325. doi: 10.1007/s00467-016-3517-z
  35. Yüksel S, Evrengül H, Özçakar ZB, Becerir T, Yalçın N, Korkmaz E, Ozaltin F. First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients. Paediatr Drugs. 2016 Dec;18(6):413-420. doi: 10.1007/s40272-016-0194-0
  36. Zhu J, Chaki M, Lu D, Ren C, Wang SS, Rauhauser A, Li B, Zimmerman S, Jun B, Du Y, Vadnagara K, Wang H, Elhadi S, Quigg RJ, Topham MK, Mohan C, Ozaltin F, Zhou XJ, Marciano DK, Bazan NG, Attanasio M. Loss of diacylglycerol kinase epsilon in mice causes endothelial distress and impairs glomerular Cox-2 and PGE2 production. Am J Physiol Renal Physiol. 2016 May 1;310(9):F895-908. doi: 10.1152/ajprenal.00431.2015
  37. Braun DA, Sadowski CE, Kohl S, Lovric S, Astrinidis SA, Pabst WL, Gee HY, Ashraf S, Lawson JA, Shril S, Airik M, Tan W, Schapiro D, Rao J, Choi WI, Hermle T, Kemper MJ, Pohl M, Ozaltin F, Konrad M, Bogdanovic R, Büscher R, Helmchen U, Serdaroglu E, Lifton RP, Antonin W, Hildebrandt F. Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome. Nat Genet. 2016 Apr;48(4):457-65. doi: 10.1038/ng.3512.
  38. Braun DA, Schueler M, Halbritter J, Gee HY, Porath JD, Lawson JA, Airik R, Shril S, Allen SJ, Stein D, Al Kindy A, Beck BB, Cengiz N, Moorani KN, Ozaltin F, Hashmi S, Sayer JA, Bockenhauer D, Soliman NA, Otto EA, Lifton RP, Hildebrandt F. Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity. Kidney Int. 2016 Feb;89(2):468-475. doi: 10.1038/ki.2015.317
  39. Korkmaz E, Lipska-Ziętkiewicz BS, Boyer O, Gribouval O, Fourrage C, Tabatabaei M, Schnaidt S, Gucer S, Kaymaz F, Arici M, Dinckan A, Mir S, Bayazit AK, Emre S, Balat A, Rees L, Shroff R, Bergmann C, Mourani C, Antignac C, Ozaltin F, Schaefer F; PodoNet Consortium. ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS. J Am Soc Nephrol. 2016 Jan;27(1):63-8. doi: 10.1681/ASN.2014121240.
  40. Cil O, Besbas N, Duzova A, Topaloglu R, Peco-Antić A, Korkmaz E, Ozaltin F. Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome. Pediatr Nephrol. 2015 Aug;30(8):1279-87. doi: 10.1007/s00467-015-3058-x
  41. Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Özkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F; PodoNet Consortium. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol. 2015 Apr 7;10(4):592-600. doi: 10.2215/CJN.06260614

Bağlantılar

Resmi Web Adresi
nephrogenetics.hacettepe.edu.tr

Hakkında

Herediter böbrek hastalıklarının genetiğine adanmış rutin diagnostik ve araştırma temelli çalışmaların yürütüldüğü Türkiye’nin ilk Nefrogenetik laboratuvarıdır.

Araştırma Olanakları

•    Konvansiyonel Termal Cycler (3 adet)
•    Real-Time PCR (1 adet)
•    Sekans cihazı (Applied 3130)
•    İkinci nesil dizileme cihazı (S5 ve Ion Chef sistem)
•    Normal ve soğutmalı santrifüj (2 adet)
•    DNA konsantratörü, derin dondurucu (-80 ve -20)
•    Sıvı nitrojen tankı (-180)
•    Class II biyolojik güvenlik kabini
•    İnverted mikroskop
•    Buzdolapları (2 adet)
•    Jel elektroforez sistemleri (konvansiyonel ve otomatik)
•    DNA/RNA izolasyon robotu

Araştırmacılar

•    Prof. Dr. Fatih Özaltın
•    Biyolog Dr. Emine Atayar
•    Biyolog Doruk Taylan
•    Teknisyen Serpil Solmaz
•    Teknisyen Mustafa Baran

Devam Eden Projeler

  • Adolesan başlangıçlı atipik hemolitik üremik sendrom hastalarında kompleman düzenleyici genlerdeki mutasyonların saptanması ve hastaların klinik özelliklerinin incelenmesi (H.Ü. Kapsamlı Araştırma Projesi-TSA-2019-18022)
  • Kalıtsal Nadir Böbrek Hastalıklarında Yeni Genlerin Araştırılması (Cerrahpaşa Tıp Fakültesi ÖNAP Projesi-TOA-2021-35349)
     

Tamamlanan Projeler

  •  Çocukluk Çağı Otozomal Dominant ve Otozomal Resesif Polikistik Böbrek Hastalıklarının Genetik ve Klinik Özelliklerinin Araştırılması (H.Ü. Tıpta Uzmanlık Tez Projesi- TTU-2019-17817)
  • EURenOmics (European Consortium for High-Throughput Research in Rare Kidney Diseases) (AB 7.Çerçeve projesi (Proje No: 305608)
  •  Atipik Hemolitik Üremik Sendromlu Hastalarda Kompleman Düzenleyici Genlerdeki Mutasyonların Saptanması (HÜ Araştırma Projesi-010 A 101 009-104)
  • Çocuk çağı böbrek hastalıklarında yeni genlerin tanımlanması (İstanbul Üniversitesi Cerrahpaşa BAP Projesi, Proje No: 55436)
  • CoQ10 Nefropatisinde Koenzim Q10 İçerikli Nanoterapötiklerin Tedavi Etkiliğinin Araştırılması ve İn Vitro Modelde Mitokondriyal Fonksiyonlarının Karşılaştırılması (HÜ Kapsamlı Araştırma Projesi-TSA-2018-16993)
  • Nadir Bir Hastalık Olan Sistinozis Tanısında ve İzleminde Kullanılabilecek Yeni Biyobelirteçlerin Araştırılması: Klinik ve İn Vitro Temelli Multiomik (Genomik, Proteomik, Metabolomik ve Fluksomik) Çalışmalar (TÜBİTAK 1001 projesi-118S578)

Yayınlar

  1. Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schreuder MF, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Liu C, Sun S, Deng F, Wang X, Clavé S, Stańczyk M, Bałasz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G; PodoNet Consortium; MitoNet Consortium; CCGKDD Consortium, Schaefer F. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency. Kidney Int. 2022 May 25:S0085-2538(22)00379-9. doi: 10.1016/j.kint.2022.04.029
  2. Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Ziętkiewicz S, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schijvens AM, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Deng F, Rousset-Rouviere C, Stańczyk M, Bałasz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G; PodoNet Consortium; mitoNET Consortium; CCGKDD Consortium, Schaefer F. Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy. Kidney Int. 2022 Apr 26:S0085-2538(22)00338-6. doi: 10.1016/j.kint.2022.02.040
  3. Sena Ozbay H, Yabanoglu-Ciftci S, Baysal I, Gultekinoglu M, Can Eylem C, Ulubayram K, Nemutlu E, Topaloglu R, Ozaltin F. Mitochondria-Targeted CoQ 10 Loaded PLGA-b-PEG-TPP Nanoparticles: Their Effects on Mitochondrial Functions of COQ8B -/- HK-2 cells. Eur J Pharm Biopharm. 2022 Feb 26:S0939-6411(22)00039-X. doi: 10.1016/j.ejpb.2022.02.018
  4. Baskin E, Fidan K, Gulhan B, Gulleroglu K, Canpolat N, Yilmaz A, Parmakiz G, Özçakar ZB, Ozaltin F, Soylemezoglu O. Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study. J Nephrol 2022 Jan 21. doi: 10.1007/s40620-021-01212-w
  5. Yılmaz EK, Saygili S, Gulhan B, Canpolat N, Bayazıt AK, Kilic BD, Akıncı N, Benzer M, Goknar N, Tufan AK, Kalyoncu M, Nalcacioglu H, Tekcan D, Yıldız G, Agbas A, Nayır A, Topaloglu R, Caliskan S, Ozaltin F. A broad clinical spectrum of PLCε1-related kidney disease and intrafamilial variability. Pediatr Nephrol. 2022; 16. doi: 10.1007/s00467-021-05371-7
  6. Airik M, McCourt B, Ozturk TT, Huynh AB, Zhang X, Tometich JT, Topaloglu R, Ozen H, Orhan D, Nejak-Bowen K, Monga SP, Hand TW, Ozaltin F, Airik R. Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion  FASEB J. 2022 Feb;36(2):e22157
  7. Özlü SG, Gülhan B, Aydoğ Ö, Atayar E, Delibaş A, Parmaksız G, Özdoğan EB, Çomak E, Taşdemir M, Acar B, Özçakar ZB, Topaloğlu R, Söylemezoğlu O, Özaltın F. Could plasma based therapies still be considered in selected cases with atypical hemolytic uremic syndrome? Turk J Pediatr. 2021;63: 986-993
  8. Canpolat N, Liu D, Atayar E, Saygili S, Kara NS, Westfall TA, Ding Q, Brown BJ, Braun TA, Slusarski D, Karli Oguz K, Ozluk Y, Tuysuz B, Tastemel Ozturk T, Sever L, Sezerman OU, Topaloglu R, Caliskan S, Attanasio M, Ozaltin F. A splice site mutation in the TSEN2 causes a new syndrome with craniofacial and central nervous system malformations, and atypical hemolytic uremic syndrome. Clin Genet. 2022; 101: 346-358
  9. Emma F, Hoff WV, Hohenfellner K, Topaloglu R, Greco M, Ariceta G, Bettini C, Bockenhauer D, Veys K, Pape L, Hulton S, Collin S, Ozaltin F, Servais A, Deschênes G, Novo R, Bertholet-Thomas A, Oh J, Cornelissen E, Janssen M, Haffner D, Ravà L, Antignac C, Devuyst O, Niaudet P, Levtchenko E. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis. Kidney Int. 2021; 100: 1112-1123
  10. Boyer O, Schaefer F, Haffner D, Bockenhauer D, Hölttä T, Bérody S, Webb H, Heselden M, Lipska-Zie Tkiewicz BS, Ozaltin F, Levtchenko E, Vivarelli M. Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group. Nat Rev Nephrol. 2021 Apr;17(4):277-289. doi: 10.1038/s41581-020-00384-1.
  11. Demir S, Gülhan B, Özen S, Çeleğen K, Batu ED, Taş N, Orhan D, Bilginer Y, Düzova A, Ozaltin F, Topaloğlu R. Long term renal survival of pediatric patients with lupus nephritis.Nephrol Dial Transplant. 2021 Apr 7:gfab152. doi: 10.1093/ndt/gfab152.
  12. Demirgan EB, Saygili S, Canpolat N, Sever L, Kilicaslan I, Taylan D, Caliskan S, Ozaltin F. AGTR1-related renal tubular dysgeneses may not be fatal. Kidney Int Rep. 2020 Dec 13;6(3):846-852. doi: 10.1016/j.ekir.2020.11.033.
  13. Özçakar ZB, Ozaltin F, Gülhan B et al. Transplantation in pediatric aHUS within the era of eculizumab therapy. Pediatr Transplant. 2021 May;25(3):e13914. doi: 10.1111/petr.13914.
  14. Topaloglu R, Keser AG, Gülhan B, Ozaltin F, Demir H, Çiftci T, Demir N, Temucin ÇM, Yuce A, Akhan O. Cystinosis beyond kidneys: gastrointestinal system and muscle involvement. BMC Gastroenterol. 2020 Jul 29;20(1):242. doi: 10.1186/s12876-020-01385-x
  15. Saygili S, Atayar E, Canpolat N, Elicevik M, Kurugoglu S, Sever L, Caliskan S, Ozaltin F. A homozygous HOXA11 variation as a potential novel cause of autosomal recessive congenital anomalies of the kidney and urinary tract. Clin Genet. 2020 Oct;98(4):390-395. doi: 10.1111/cge.13813.
  16. Ozdemir G, Gulhan B, Atayar E, Saygılı S, Soylemezoglu O, Ozcakar ZB, Eroglu FK, Candan C, Demir BK, Soylu A, Yüksel S, Alpay H, Agbas A, Duzova A, Hayran M, Ozaltin F, Topaloglu R. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome. Pediatr Nephrol. 2020 Oct;35(10):1941-1952. doi: 10.1007/s00467-020-04574-8.
  17. Atmaca M, Gülhan B, Atayar E, Bayazıt AK, Candan C, Arıcı M, Topaloğlu R, Özaltın F. Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementation. Turk J Pediatr. 2019;61(5):657-663. doi: 10.24953/turkjped.2019.05.003
  18. Güngör T, Eroğlu FK, Kargın Çakıcı E, Yazılıtaş F, Can G, Çelikkaya E, Karakaya D, Kurt Şükür ED, Özaltın F, Yağız B, Bülbül M. Gastric duplication cyst in an infant with Finnish-type congenital nephrotic syndrome: concurrence or coincidence? Acta Clin Belg. 2019 Oct 5:1-3. doi: 10.1080/17843286.2019.1675333
  19. Eroglu FK, Ozaltin F, Gönç N, Nalçacıoğlu H, Özçakar ZB, Yalnızoğlu D, Güçer Ş, Orhan D, Eminoğlu FT, Göçmen R, Alikaşifoğlu A, Topaloğlu R, Düzova A. Response to Early Coenzyme Q10 Supplementation Is not Sustained in CoQ10 Deficiency Caused by CoQ2 Mutation. Pediatr Neurol. 2018 Nov;88:71-74. doi: 10.1016/j.pediatrneurol.2018.07.008
  20. Akyol A, Güner G, Özşeker HS, Işık A, Atcı Ö, Uzun S, Atayar E, Ozaltin F, Gedikoğlu G, Sökmensüer C, Fearon ER. An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues. Lab Invest. 2019 Jan;99(1):128-137. doi: 10.1038/s41374-018-0121-9.
  21. Sürmeli-Döven S, Delibaş A, Gürses İ, Kayacan UR, Coşkun-Yılmaz B, Esen K, Korkmaz E, Özaltın F. Hemolytic uremic syndrome and IgA nephropathy in a child: Coincidence or not? Turk J Pediatr. 2018;60(1):81-85. doi: 10.24953/turkjped.2018.01.012
  22. Saygili S, Canpolat N, Sever L, Caliskan S, Atayar E, Ozaltin F. Persistent hypoglycemic attacks during hemodialysis sessions in an infant with congenital nephrotic syndrome: Answers. Pediatr Nephrol. 2019 Jan;34(1):77-79. doi: 10.1007/s00467-018-3982-7.
  23. Saygili S, Canpolat N, Sever L, Caliskan S, Atayar E, Ozaltin F. Persistent hypoglycemic attacks during hemodialysis sessions in an infant with congenital nephrotic syndrome: Questions. Pediatr Nephrol. 2019 Jan;34(1):75-76. doi: 10.1007/s00467-018-3980-9.
  24. Fidan K, Göknar N, Gülhan B, Melek E, Yıldırım ZY, Baskın E, Hayran M, Gülleroglu K, Özçakar ZB, Ozaltin F, Soylemezoglu O. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2018 Aug;33(8):1395-1403. doi: 10.1007/s00467-018-3933-3
  25. Çakar N, Ozcakar ZB, Ozaltin F, Koyun M, Celikel Acar B, Bahat E, Gulhan B, Korkmaz E, Yurt A, Yılmaz S, Soylemezoglu O, Yalcinkaya F. Atypical Hemolytic Uremic Syndrome in Children Aged <2 Years. Nephron. 2018;139(3):211-218. doi: 10.1159/000487609. Epub 2018 Mar 13.
  26. Warejko JK, Tan W, Daga A, Schapiro D, ……., Ozaltin F, ……Lifton RP, Braun DA, Hildebrandt F. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2018 Jan 6;13(1):53-62. doi: 10.2215/CJN.04120417
  27. Braun DA, Rao J, Mollet G, Schapiro D, ……. Ozaltin F, ………., Zenker M, Antignac C, Hildebrandt F. Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly. Nat Genet. 2017 Oct;49(10):1529-1538. doi: 10.1038/ng.3933
  28. Lipska-Ziętkiewicz BS, Gellermann J, Boyer O, Gribouval O, Ziętkiewicz S, Kari JA, Shalaby MA, Ozaltin F, Dusek J, Melk A, Bayazit AK, Massella L, Hyla-Klekot L, Habbig S, Godron A, Szczepańska M, Bieniaś B, Drożdż D, Odeh R, Jarmużek W, Zachwieja K, Trautmann A, Antignac C, Schaefer F; PodoNet Consortium. Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia. PLoS One. 2017 Aug 10;12(8):e0180926. doi: 10.1371/journal.pone.0180926
  29. Topaloglu R, Gulhan B, İnözü M, Canpolat N, Yilmaz A, Noyan A, Dursun İ, Gökçe İ, Gürgöze MK, Akinci N, Baskin E, Serdaroğlu E, Demircioğlu Kiliç B, Yüksel S, Övünç Hacihamdioğlu D, Korkmaz E, Hayran M, Ozaltin F; contributors of The Turkish Cystinosis Study Group. The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis. Clin J Am Soc Nephrol. 2017 Aug 9;12(10):1634-41. doi: 10.2215/CJN.00180117
  30. Trautmann A, Schnaidt S, Lipska-Ziętkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F; PodoNet Consortium. Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. J Am Soc Nephrol. 2017 Oct;28(10):3055-3065. doi: 10.1681/ASN.2016101121
  31. Kayki G, Bozkaya D, Ozaltin F, Orhan D, Kaymaz F, Korkmaz E, Yigit S. Epidermolysis Bullosa with Pyloric Atresia and Aplasia Cutis in a Newborn Due to Homozygous Mutation in ITGB4. Fetal Pediatr Pathol. 2017 Aug;36(4):332-339. doi: 10.1080/15513815.2017.1324545
  32. Atmaca M, Gulhan B, Korkmaz E, Inozu M, Soylemezoglu O, Candan C, Bayazıt AK, Elmacı AM, Parmaksiz G, Duzova A, Besbas N, Topaloglu R, Ozaltin F. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment. Pediatr Nephrol. 2017 Aug;32(8):1369-1375. doi: 10.1007/s00467-017-3634-3
  33. Besbas N, Gulhan B, Soylemezoglu O, Ozcakar ZB, Korkmaz E, Hayran M, Ozaltin F. Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients. BMC Nephrol. 2017 Jan 5;18(1):6. doi: 10.1186/s12882-016-0420-6.
  34. Hölttä T, Bonthuis M, Van Stralen KJ, Bjerre A, Topaloglu R, Ozaltin F, Holmberg C, Harambat J, Jager KJ, Schaefer F, Groothoff JW. Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry. Pediatr Nephrol. 2016 Dec;31(12):2317-2325. doi: 10.1007/s00467-016-3517-z
  35. Yüksel S, Evrengül H, Özçakar ZB, Becerir T, Yalçın N, Korkmaz E, Ozaltin F. First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients. Paediatr Drugs. 2016 Dec;18(6):413-420. doi: 10.1007/s40272-016-0194-0
  36. Zhu J, Chaki M, Lu D, Ren C, Wang SS, Rauhauser A, Li B, Zimmerman S, Jun B, Du Y, Vadnagara K, Wang H, Elhadi S, Quigg RJ, Topham MK, Mohan C, Ozaltin F, Zhou XJ, Marciano DK, Bazan NG, Attanasio M. Loss of diacylglycerol kinase epsilon in mice causes endothelial distress and impairs glomerular Cox-2 and PGE2 production. Am J Physiol Renal Physiol. 2016 May 1;310(9):F895-908. doi: 10.1152/ajprenal.00431.2015
  37. Braun DA, Sadowski CE, Kohl S, Lovric S, Astrinidis SA, Pabst WL, Gee HY, Ashraf S, Lawson JA, Shril S, Airik M, Tan W, Schapiro D, Rao J, Choi WI, Hermle T, Kemper MJ, Pohl M, Ozaltin F, Konrad M, Bogdanovic R, Büscher R, Helmchen U, Serdaroglu E, Lifton RP, Antonin W, Hildebrandt F. Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome. Nat Genet. 2016 Apr;48(4):457-65. doi: 10.1038/ng.3512.
  38. Braun DA, Schueler M, Halbritter J, Gee HY, Porath JD, Lawson JA, Airik R, Shril S, Allen SJ, Stein D, Al Kindy A, Beck BB, Cengiz N, Moorani KN, Ozaltin F, Hashmi S, Sayer JA, Bockenhauer D, Soliman NA, Otto EA, Lifton RP, Hildebrandt F. Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity. Kidney Int. 2016 Feb;89(2):468-475. doi: 10.1038/ki.2015.317
  39. Korkmaz E, Lipska-Ziętkiewicz BS, Boyer O, Gribouval O, Fourrage C, Tabatabaei M, Schnaidt S, Gucer S, Kaymaz F, Arici M, Dinckan A, Mir S, Bayazit AK, Emre S, Balat A, Rees L, Shroff R, Bergmann C, Mourani C, Antignac C, Ozaltin F, Schaefer F; PodoNet Consortium. ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS. J Am Soc Nephrol. 2016 Jan;27(1):63-8. doi: 10.1681/ASN.2014121240.
  40. Cil O, Besbas N, Duzova A, Topaloglu R, Peco-Antić A, Korkmaz E, Ozaltin F. Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome. Pediatr Nephrol. 2015 Aug;30(8):1279-87. doi: 10.1007/s00467-015-3058-x
  41. Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Özkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F; PodoNet Consortium. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol. 2015 Apr 7;10(4):592-600. doi: 10.2215/CJN.06260614

Bağlantılar

Resmi Web Adresi
nephrogenetics.hacettepe.edu.tr